Journal article · 2026 · Open access

Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years

Camilla Nystrand, Naimi Johansson, Johannes Blom

PharmacoEconomics · Published 22 September 2026 · DOI 10.1007/s40273-026-01652-x

Free PDFView at the publisherCite this paper

In brief

“Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years” is a 2026 journal article by Camilla Nystrand and 2 co-authors, published in PharmacoEconomics. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at PharmacoEconomics.

Citations
0
References
40
Authors
3

Abstract

BACKGROUND: Comorbidity indices are widely applied to adjust for confounding in observational research. However, health economic analyses often adjust for comorbidity using mortality-based indices, despite health conditions being likely associated differently, both in terms of magnitude and direction, to resource use than to mortality. OBJECTIVE: We aimed to derive outcome-specific cost-based indices based on the Charlson, Elixhauser and RxRisk comorbidity measures, and to internally validate their performance for predicting annual healthcare costs compared with published mortality-based weights. METHODS: Using a retrospective register-based design with 11 years of data, diagnostic (International Classification of Diseases, Tenth Revision) and Anatomical Therapeutic Chemical (prescribed drugs) codes determined whether 350,000+ individuals had one or several of the disease categories defined by each comorbidity index. Outcomes were annual total healthcare costs (primary, specialised and inpatient care, prescribed drugs) and inpatient costs. Prediction models were two-part generalised linear models, adjusting for age in splines, sex and year fixed effects. Internal validation with repeated cross-validation assessed predictive performance. Calibration curves with bootstrapped variance were plotted, and improvement in prediction between mortality- and cost-based indices was assessed. RESULTS: The cost-based RxRisk index was better in terms of calibration and performed significantly better than the original mortality-based RxRisk in predicting total healthcare and inpatient costs. The mortality- and cost-based Charlson models showed inconclusive results in relation to prediction accuracy, while well calibrated. The cost-based Elixhauser index reduced prediction errors and significantly improved explained variance compared with the mortality-based index. Decile calibration plots illustrate the superior comparative advantage of RxRisk across groups, where observed versus predicted mean cost deviation averaged 7% across deciles using the cost-based RxRisk, whereas the Charlson and Elixhauser indices deviated 32-40%. CONCLUSIONS: In future research, when using a comorbidity index to adjust for confounding in cost analyses, our results suggest using the cost-based RxRisk index.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nystrand, C., Johansson, N., & Blom, J. (2026). Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01652-x

MLA 9

Nystrand, Camilla, et al. “Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years.” PharmacoEconomics, 2026. https://doi.org/10.1007/s40273-026-01652-x.

Chicago

Nystrand, Camilla, Naimi Johansson, and Johannes Blom. 2026. “Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years.” PharmacoEconomics. https://doi.org/10.1007/s40273-026-01652-x.

Harvard

Nystrand, C., Johansson, N. and Blom, J. (2026) ‘Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years’, PharmacoEconomics. doi:10.1007/s40273-026-01652-x.

IEEE

C. Nystrand, N. Johansson, and J. Blom, “Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years,” PharmacoEconomics, 2026, doi: 10.1007/s40273-026-01652-x.

BibTeX

@article{nystrand2026derivation,
  title     = {{Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years}},
  author    = {Nystrand, Camilla and Johansson, Naimi and Blom, Johannes},
  journal   = {PharmacoEconomics},
  year      = {2026},
  doi       = {10.1007/s40273-026-01652-x},
  url       = {https://doi.org/10.1007/s40273-026-01652-x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies

  • comorbidity index
  • Charlson Comorbidity Index
  • Elixhauser comorbidity index
  • health care costs
  • hospital costs
  • cost prediction
  • calibration
  • confounding adjustment

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Nystrand, C., Johansson, N., & Blom, J. (2026). Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01652-x

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at PharmacoEconomics.

Who wrote this paper?

Camilla Nystrand, Naimi Johansson, Johannes Blom.

What is the DOI of this paper?

10.1007/s40273-026-01652-x. The permanent link is https://doi.org/10.1007/s40273-026-01652-x.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.